Drug Trial Radar · NCT04832880
Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)
Last checked: Nov 20, 2026Latest source record: Apr 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4,000
Planned (sponsor's estimate)
Start
Apr 6, 2021
Primary completion
Mar 2022
Study completion Dec 2022
Sponsor
- Lead sponsor
- ASST Fatebenefratelli SaccoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 6, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Background: In the current worldwide medical emergency, a rapid identification of effective therapeutic strategy is crucial. So far, therapy with dexamethasone, remdesivir and baricitinib have been associated with evidence of impact on the clinical impact on COVID-19, but the effect of baricitinib and remdesivir in combination with dexamethasone. The AAMMURAVID trial is endorced and supported by the Italian Regulatory agency (AIFA-Agenzia Italiana del Farmaco)
Conditions
- Covid19
Interventions
Baricitinib Oral Tablet [Olumiant]Drug
Baricitinib 4 mg die (2 mg for patients aged \> 75 years) for 10 days.
RemdesivirDrug
Intravenous remdesivir 200 mg on day 1, followed by remdesivir 100 mg die until day 10
DexamethasoneDrug
Intravenous dexamethasone 6 mg for 10 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevention of very severe respiratory failure or mortalityTime frame: Day1-Day 28
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Ospedali Riuniti delle Marche
Ancona, Italy
Ospedale Parini
Aosta, Italy
Ospedale SS Annunziata -Chieti
Chieti, Italy
Ospedale S Anna
Como, Italy
Ospedale di Ferrara
Ferrara, Italy
Ospedale di Firenze and Empoli
Florence, Italy
Ospedali Galliera
Genova, Italy
H Goretti
Latina, Italy
Ospedale Manzoni
Lecco, Italy
Ospedale di Legnago
Legnago, Italy
Ospedale di Legnano
Legnano, Italy
ASST Fatebenefratelli-Sacco
Milan, Italy
ASST Santi Paolo e Carlo
Milan, Italy
IRCCS San Raffaele
Milan, Italy
Ospedale di Perugia
Perugia, Italy
Ospedale San Salvatore
Pesaro, Italy
Ospedali di Prato e Pistoia
Prato, Italy
Policlinico Tor Vergata
Roma, Italy
Ospedale Cattinara e Maggiore
Trieste, Italy
Ospedale di Udine
Udine, Italy
Azienda Ospedaliera Integrata -Verona
Verona, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.